Jane Street’s INmune Bio INMB Stock Holding History

Jane Street’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$57.6K	Buy	50,944 +27,987	+122%	+$39.9K	﹤0.01%	10913
2025 Q4	$35.8K	Sell	22,957 -26,617	-54%	-$47.5K	﹤0.01%	10596
2025 Q3	$103K	Buy	+49,574	New	+$113K	﹤0.01%	10121
2025 Q2	–	Sell	-18,159	Closed	-$142K	–	10218
2025 Q1	$142K	Buy	+18,159	New	+$144K	﹤0.01%	8644
2024 Q4	–	Sell	-14,725	Closed	-$79.4K	–	9970
2024 Q3	$79.4K	Buy	+14,725	New	+$105K	﹤0.01%	9069
2024 Q2	–	Sell	-73,970	Closed	-$869K	–	9762
2024 Q1	$869K	Buy	73,970 +30,836	+71%	+$373K	﹤0.01%	5664
2023 Q4	$486K	Buy	+43,134	New	+$362K	﹤0.01%	6808
2022 Q1	–	Sell	-17,098	Closed	-$175K	–	10649
2021 Q4	$175K	Buy	+17,098	New	+$253K	﹤0.01%	8913
2021 Q2	–	Sell	-12,221	Closed	-$145K	–	10074
2021 Q1	$145K	Buy	+12,221	New	+$220K	﹤0.01%	8472

Other funds holding INMB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street's INMB Position: Q1 2026 in Review

Jane Street increased its INmune Bio (INMB) stake by 122% in Q1 2026, buying an estimated $39.9K and bringing the position to 50,944 shares worth $57.6K. The position accounts for ﹤0.01% of the portfolio, ranked #10913.

Jane Street first reported a position in INMB in Q1 2021 and has held it in 9 quarters since. The position peaked at $869K in Q1 2024. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

Jane Street held 50,944 shares of INmune Bio worth $57.6K as of Q1 2026.
Jane Street bought 27,987 INmune Bio shares in Q1 2026, an estimated $39.9K.
INmune Bio made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10913 holding.
Jane Street first reported a position in INmune Bio in Q1 2021 and has held it in 9 quarters since.
Jane Street's INmune Bio position peaked at $869K in Q1 2024.
82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.